MANF is too pre-clinical my friend. For now, we ar
Post# of 30028
Posted On: 11/17/2014 12:09:50 PM
MANF is too pre-clinical my friend. For now, we are about LymPro. But Lympro is not nearly as valuable now as it will be a year or two from now.
I say Gerald spins off the diagnostic division to existing shareholders first....and then a sale of that division might happen down the road.
MANF orphan will help our value a bit, but we won't see big MANF value for a couple more years!!
LymPro$$$$$LymPro$$$$LymPro$$$$
I say Gerald spins off the diagnostic division to existing shareholders first....and then a sale of that division might happen down the road.
MANF orphan will help our value a bit, but we won't see big MANF value for a couple more years!!
LymPro$$$$$LymPro$$$$LymPro$$$$
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼